A significant discovery in cancer research is arising with the use of VHH fragments to reactivate mutated p53. This vital cancer inhibitor protein is frequently disabled in various forms of malignancies, leading https://bookmarkbells.com/story22028660/vhh-fragments-reactivate-the-p53-protein-a-promising-approach-for-tumor-therapy